Adverse event profiles of the two regimens were fairly similar : overall adverse events , 48 % ferumoxytol versus 65 % iron sucrose ; related adverse events , 10 % ferumoxytol versus 16 % iron sucrose ; and adverse events leading to study discontinuation , 1 % ferumoxytol versus 5 % iron sucrose .